featured
Afamitresgene Autoleucel for Advanced Synovial Sarcoma and Myxoid Round Cell Liposarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
Lancet 2024 Mar 27;[EPub Ahead of Print], SP D'Angelo, DM Araujo, AR Abdul Razak, M Agulnik, S Attia, JY Blay, I Carrasco Garcia, JA Charlson, E Choy, GD Demetri, M Druta, E Forcade, KN Ganjoo, J Glod, VL Keedy, A Le Cesne, DA Liebner, V Moreno, SM Pollack, SM Schuetze, GK Schwartz, SJ Strauss, WD Tap, F Thistlethwaite, CM Valverde Morales, MJ Wagner, BA Wilky, C McAlpine, L Hudson, JM Navenot, T Wang, J Bai, S Rafail, R Wang, A Sun, L Fernandes, E Van Winkle, E Elefant, C Lunt, E Norry, D Williams, S Biswas, BA Van TineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.